Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
China Journal of Chinese Materia Medica ; (24): 733-737, 2014.
Article in Chinese | WPRIM | ID: wpr-300159

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of Zige lyophilized powder for injection in improving the acute cerebral microcirculation disturbance in rats.</p><p><b>METHOD</b>Window craniotomy was performed for rats after the drug administration for 14 days. The experimental microcirculation disturbance model was duplicated with high molecule dextran. After the drug administration, the micro-vein diameters of cerebral pla mater of various groups were observed and recorded under the biological microscope. The blood flow volume was monitored by laser Doppler flow-meter. HCT was measured by the electric resistance method. The hemorheological indexes were detected by the auto-hemorheological instrument.</p><p><b>RESULT</b>Zige lyophilized powder for injection (16.40, 32.70, 65.40 mg x kg(-1)) could significantly expand the micro-vein diameter of cerebral pla mater, improve the downward trend of the blood flow volume, and reduce the various hemorheological indexes.</p><p><b>CONCLUSION</b>Zige lyophilized powder for injection shows the effect in improving the cerebral microcirculation.</p>


Subject(s)
Animals , Humans , Male , Rats , Brain , Brain Ischemia , Drug Therapy , Cerebrovascular Circulation , Drugs, Chinese Herbal , Powders , Rats, Sprague-Dawley
2.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 588-595, 2013.
Article in English | WPRIM | ID: wpr-812653

ABSTRACT

The treatment of cerebral ischemic disease by natural medicines has a long history, and has accumulated a rich theoretical knowledge and treatment experience. The objective of this review is to critically evaluate the experimental research situation of the protective effect of the individual compounds from natural medicine on cerebral ischemia in the past ten years, emphasizing the major mechanisms underlying cerebral ischemic pathophysiology. Sixteen representative compounds from natural medicines which are often used to treat stroke are discussed. The results indicate that these components possess a protective effect on cerebral ischemia, and that these components have different mechanisms, including inhibiting excitotoxicity by ginkgolide B, antiapoptosis of breviscapine, influencing astrocytic activation and proliferation of tanshinone IIA, influencing free radicals by ginsenoside Rd, impairing blood-brain barrier disruption by baicalin, and the anti-inflammatory activity of tetramethylpyrazine. Moreover, some components have multiple neuroprotective mechanisms. Therefore, the combination of individual compounds from natural medicines, considering the mechanisms of cerebral ischemia, may be beneficial to patients with cerebral ischemia in the future. This approach will provide a direction for the further application and exploitation of new drug development in the treatment of cerebral ischemia.


Subject(s)
Animals , Humans , Brain Ischemia , Drug Therapy , Drugs, Chinese Herbal , Therapeutic Uses , Phytotherapy , Plants, Medicinal , Chemistry
3.
Chinese Journal of Industrial Hygiene and Occupational Diseases ; (12): 28-32, 2011.
Article in Chinese | WPRIM | ID: wpr-293764

ABSTRACT

<p><b>OBJECTIVE</b>To detect the expression and the CpG island methylation status of tumor suppressor gene p15 after exposure to 1,4-benzoquinone (1,4-BQ) in primary cultivated C57BL/6J mouse bone marrow cells in vitro.</p><p><b>METHODS</b>The mouse bone marrow cells were isolated in vitro. The effect of 0, 0.1, 1, 5, 10, 20, and 40 µmol/L 1,4-BQ on cell viability (CKK-8) was detected. 0, 0.1, 1, 10 µmol/L 1,4-BQ were used to intoxicate the mouse bone marrow cells for 24 h; Real-time PCR was employed to analyze the mRNA expression level of p15; The bisulfite sequencing PCR (BSP) was used to look into the methylation status of CpG islands in p15 promoter region.</p><p><b>RESULTS</b>1,4-BQ exhibited dose-dependent toxicity to mouse bone marrow cells, and the LC(50) was 8.3 µmol/L (95%CI: 4.6 - 10.6 µmol/L). The mRNA expression of p15 in 10 µmol/L group was only equivalent to 43% of control group. Compared with control group, the decrease of p15 mRNA expression in1 and 10 µmol/L concentration were obvious, and the differences had statistical significance (P < 0.05 or P < 0.01). BSP sequencing results were same between the exposure groups and control group, the 56 CpG sites on CpG islands remained in the state of unmethylated.</p><p><b>CONCLUSION</b>mRNA expression of p15 gene decreases after exposure to 1,4-BQ, but the CpG islands methylation status in promoter is not affected, suggesting that methylation does not participate in 1,4-BQ-mediated p15 gene expression decrease, other effect mechanisms still need to be investigated.</p>


Subject(s)
Animals , Mice , Base Sequence , Benzoquinones , Toxicity , Bone Marrow Cells , Metabolism , Cells, Cultured , CpG Islands , Cyclin-Dependent Kinase Inhibitor p15 , Genetics , DNA Methylation , Environmental Exposure , Mice, Inbred C57BL , Promoter Regions, Genetic , RNA, Messenger , Genetics
SELECTION OF CITATIONS
SEARCH DETAIL